InvestorsHub Logo
icon url

Threes

09/21/16 9:24 AM

#272938 RE: peregr #272936

Then why did they stop the trial.
This does not make sense.
icon url

corporalagarn

09/21/16 9:28 AM

#272940 RE: peregr #272936

What were the results of the docetaxel "off the charts" control arm?

I missed it.
icon url

chevalblanc-47

09/21/16 10:09 AM

#272965 RE: peregr #272936

interesting observation......we could be at 15 months plus...
icon url

exwannabe

09/21/16 11:59 AM

#272989 RE: peregr #272936

And don't overlook this nuance. The Bavi/biomarker beat the docetaxel control arm which was off the charts.


Edit: I read the PR wrong.

Still has a long ways to go before it means much though.
icon url

nh

09/21/16 2:46 PM

#273022 RE: peregr #272936

And don't overlook this nuance. The Bavi/biomarker beat the docetaxel control arm which was off the charts.



And the standard of care is still in effect, which is lower than the control arm results.

So if patient tests positive for referenced biomarkers, will this become a tx option?